```html

Small Intestinal Bacterial Overgrowth (SIBO) – A Patient‑Friendly Guide

Overview

Small intestinal bacterial overgrowth (SIBO) is a condition in which excessive numbers of bacteria, usually those that belong in the colon, proliferate in the small intestine. The small intestine normally contains relatively few bacteria (≤10<sup>3</sup> colony‑forming units per milliliter). When this balance is disturbed, bacteria ferment the nutrients that pass through, producing gas, toxins, and short‑chain fatty acids that damage the intestinal lining.

Who it affects: SIBO can occur at any age but is most common in adults aged 30–70. It is seen more frequently in women (about 60 % of cases) and in individuals with underlying gastrointestinal or systemic disorders.

Prevalence: Exact rates are difficult to pin down because many cases go undiagnosed, but population‑based studies estimate that 5–15 % of the general population have SIBO, rising to >30 % in patients with irritable bowel syndrome (IBS) and up to 70 % in those with chronic pancreatitis or intestinal surgery (Mayo Clinic, 2023).

Symptoms

Symptoms arise from gas production, malabsorption, and inflammation. They may be intermittent and can mimic other gastrointestinal disorders.

Gastrointestinal symptoms

• Abdominal bloating – a feeling of fullness or swelling; often the most common complaint.
• Excessive gas (flatulence) – due to bacterial fermentation of carbohydrates.
• Abdominal pain or cramping – usually related to distention.
• Diarrhea – watery, sometimes explosive stools; can be post‑prandial.
• Constipation – less common but can occur when motility is impaired.
• Steatorrhea (fatty stools) – malabsorption of fat leading to greasy, foul‑smelling stools.
• Nausea or early satiety – feeling full after a small amount of food.

Systemic symptoms

• Unexplained weight loss – due to nutrient malabsorption.
• Fatigue – chronic low‑grade inflammation and nutrient deficiencies.
• Vitamin deficiencies – especially B12, A, D, E, and K, which require ileal absorption.
• Joint or muscle aches – secondary to nutrient shortfalls.
• Brain fog or difficulty concentrating – sometimes reported in severe cases.

Causes and Risk Factors

SIBO is usually the result of a breakdown in the normal protective mechanisms that keep bacterial populations low in the proximal small intestine.

Mechanical and anatomic factors

• Intestinal surgery – especially procedures that bypass portions of the small intestine (e.g., Roux‑en‑Y gastric bypass, ileal resection).
• Strictures, adhesions, or diverticula – create pockets where bacteria can stagnate.
• Motility disorders – conditions such as scleroderma, diabetes‑related neuropathy, or chronic opioid use slow the migrating motor complex (MMC), allowing bacterial overgrowth.

Physiologic and metabolic factors

• Low stomach acid (hypochlorhydria) – reduced acid allows oral bacteria to survive and colonize the small bowel. Common in older adults and long‑term proton‑pump inhibitor (PPI) users.
• Impaired immune function – HIV, immunosuppressive therapy, or severe malnutrition.
• Pancreatic insufficiency – less digestive enzymes lead to undigested substrates for bacterial fermentation.

Associated conditions

• Irritable bowel syndrome (IBS)
• Inflammatory bowel disease (Crohn’s disease)
• Celiac disease
• Hypothyroidism
• Systemic sclerosis
• Chronic liver disease (cirrhosis)

Risk factors you can identify

• Age > 60 years
• Female sex
• Long‑term use of acid‑suppressing medication (PPIs, H2 blockers)
• High‑dose or chronic antibiotic use (disrupts normal gut flora)
• History of abdominal surgery
• Diabetes with autonomic neuropathy
• Low‑carb or very high‑protein diets that alter intestinal pH

Diagnosis

Because SIBO symptoms overlap with many other disorders, a structured work‑up is essential.

1. Clinical assessment

• Detailed medical history, medication review, and symptom diary.
• Physical exam focusing on abdominal tenderness, bloating, and signs of malnutrition.

2. Breath testing

The most widely used non‑invasive tests measure hydrogen (H₂) and methane (CH₄) gases produced by bacterial fermentation of a carbohydrate substrate.

• Lactulose breath test (LBT) – detects excess gas within 90 minutes; sensitive for distal SIBO.
• Glucose breath test (GBT) – glucose is absorbed in the proximal small intestine, so a rise in H₂/CH₄ within 20 minutes suggests proximal SIBO.
• Positive criteria (per North American Consensus, 2021):
• Rise in H₂ ≥ 20 ppm above baseline within 90 min (LBT) or 20 min (GBT).
• Rise in CH₄ ≥ 10 ppm (indicative of “methane‑dominant” SIBO, often associated with constipation).

3. Direct small‑bowel aspirate and culture

Considered the gold standard but rarely performed because it requires endoscopy, sterile collection, and a quantitative culture threshold of ≥10<sup>5</sup> CFU/mL. Used in research or refractory cases.

4. Additional work‑up

• Blood tests: CBC, vitamin B12, folate, fat‑soluble vitamins, iron studies.
• Stool studies: rule out parasites, Clostridioides difficile, or chronic infection.
• Imaging (CT, MRI, or small‑bowel follow‑through) if structural abnormality is suspected.

Treatment Options

Therapy is aimed at eradicating excess bacteria, correcting underlying motility or structural problems, and restoring nutritional status.

1. Antibiotic regimens

Antibiotic	Typical Dose	Course Length	Notes
Rifaximin (non‑systemic)	550 mg PO × 3 daily	14 days	Effective for hydrogen‑positive SIBO; minimal systemic side effects (Mayo Clinic, 2022).
Neomycin	500 mg PO × 3 daily	7–14 days	Often combined with rifaximin for methane‑dominant SIBO.
Metronidazole	250–500 mg PO × 3 daily	7–10 days	Useful when anaerobes predominate; watch for neuropathy with prolonged use.
Ciprofloxacin or Levofloxacin	500 mg PO × 1–2 daily	7–10 days	Broad‑spectrum; reserved for resistant cases.

About 70 % of patients achieve symptom relief after an initial course, but relapse rates of 30–50 % are reported, highlighting the need for adjunct strategies (Cleveland Clinic, 2023).

2. Prokinetic agents

• Prucalopride or erythromycin low‑dose – stimulate the migrating motor complex and reduce bacterial stasis.
• Used for 4–8 weeks after antibiotics to maintain motility.

3. Dietary modifications

1. Low‑FODMAP diet – reduces fermentable substrates; beneficial for many with SIBO‑related IBS.
2. Specific Carbohydrate Diet (SCD) – eliminates most disaccharides and polysaccharides; some studies show reduced breath test positivity.
3. Re‑introduction phase after symptom control to identify personal triggers.

4. Nutrient repletion

• Vitamin B12 (intramuscular or high‑dose oral) every 1–2 months.
• Fat‑soluble vitamins (A, D, E, K) and iron if labs show deficiency.
• Probiotic supplementation – evidence mixed; strains such as Lactobacillus plantarum may help after antibiotics (NIH, 2022).

5. Management of underlying causes

• Review and taper unnecessary PPIs.
• Tight glucose control in diabetics.
• Surgical correction of strictures or blind loops when indicated.

Living with Small Intestinal Bacterial Overgrowth (SIBO)

Even after successful treatment, many patients experience recurring symptoms. Below are practical, day‑to‑day strategies.

Dietary habits

• Eat smaller, more frequent meals (4–5 times/day) to avoid overwhelming the small intestine.
• Chew food thoroughly; this aids mechanical digestion and reduces fermentable load.
• Limit high‑fructose foods (apple juice, honey), polyols (sorbitol), and certain legumes if they trigger symptoms.
• Stay hydrated—aim for 2–3 L of water daily, which promotes motility.

Gut‑friendly habits

• Walk for 15–30 minutes after meals to stimulate the MMC.
• Avoid tight clothing that can compress the abdomen.
• Limit alcohol and caffeine, both of which can impair gut motility.
• Maintain a regular sleep schedule; circadian disruption affects intestinal hormones.

Medication adherence

• Complete the entire antibiotic course, even if symptoms improve early.
• Set reminders for prokinetics or vitamin supplements.
• Discuss any side effects promptly with your clinician.

Monitoring and follow‑up

• Keep a symptom diary for at least 4 weeks after treatment to spot early recurrence.
• Repeat breath testing 2–4 weeks after finishing antibiotics if symptoms persist.
• Annual labs to track vitamin B12 and fat‑soluble vitamin levels.

Prevention

While you cannot control every risk factor, many preventive steps are within your reach.

• Use PPIs only when medically necessary and at the lowest effective dose.
• Manage chronic diseases (diabetes, hypothyroidism) aggressively.
• Limit unnecessary antibiotics; ask your provider about narrow‑spectrum options.
• Incorporate regular physical activity—30 minutes of moderate exercise most days.
• Consider periodic low‑FODMAP or SCD cycles if you have a known predisposition.
• Stay up to date with vaccinations (e.g., influenza, COVID‑19) to reduce systemic inflammation that can affect gut motility.

Complications

If left untreated, SIBO can lead to several serious health problems.

• Malnutrition and weight loss – chronic fat and protein malabsorption.
• Micronutrient deficiencies – especially vitamin B12, leading to anemia, neuropathy, and cognitive changes.
• Osteoporosis – due to impaired calcium and vitamin D absorption.
• Small‑bowel ulceration and mucosal inflammation, increasing bleeding risk.
• Progression of underlying disease – e.g., worsening IBS symptoms, accelerated motility disorders.
• Increased healthcare utilization – repeated ER visits and unnecessary procedures when diagnosis is missed.

When to Seek Emergency Care

---

**References** (accessed May 2026)

• Mayo Clinic. “Small intestinal bacterial overgrowth (SIBO).” 2023.
• North American Consensus on Breath Testing for SIBO. *American Journal of Gastroenterology*, 2021.
• Cleveland Clinic. “SIBO Treatment Options.” 2023.
• National Institutes of Health. “Probiotics and SIBO.” 2022.
• World Health Organization. “Guidelines for the Prevention and Management of Gastrointestinal Infections.” 2020.

```